Suchergebnisse - "Waldron, Peter"

PubPharm (43)

1

Inter-alpha-trypsin inhibitor (IαI) and hyaluronan modifications enhance the innate immune response to influenza virus in the lung

enthalten in: Matrix biology : journal of the International Society for Matrix Biology | 2024

von Tang, F. | Reeves, S. | Brune, J. | +10

2

Risk of Severe Abnormal Uterine Bleeding Associated with Rivaroxaban Compared with Apixaban, Dabigatran and Warfarin

enthalten in: Drug safety | 2021

von Eworuke, E. | Hou, L. | Zhang, R. | +6

3

Risk of Severe Abnormal Uterine Bleeding Associated with Rivaroxaban Compared with Apixaban, Dabigatran and Warfarin

enthalten in: Drug safety | 2021

von Eworuke, E. | Hou, L. | Zhang, R. | +6

4

Risk of Severe Abnormal Uterine Bleeding Associated with Rivaroxaban Compared with Apixaban, Dabigatran and Warfarin

enthalten in: Drug safety | 2021

von Eworuke, E. | Hou, L. | Zhang, R. | +6

5

Risk of Severe Abnormal Uterine Bleeding Associated with Rivaroxaban Compared with Apixaban, Dabigatran and Warfarin

enthalten in: Drug safety | 2021

von Eworuke, E. | Hou, L. | Zhang, R. | +6

6

FDA Approval Summary : Enfortumab Vedotin for Locally Advanced or Metastatic Urothelial Carcinoma

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2021

von Chang, E. | Weinstock, C. | Zhang, L. | +16

7

BCR-ABL1 tyrosine kinase inhibitor-associated thyroid dysfunction : A review of cases reported to the FDA Adverse Event Reporting System and published in the literature

enthalten in: American journal of hematology | 2020

von Patel, S. | Nayernama, A. | Jones, S. | +2

8

Proteasome inhibitor-associated thrombotic microangiopathy : A review of cases reported to the FDA adverse event reporting system and published in the literature

enthalten in: American journal of hematology | 2020

von Nguyen, M. | Nayernama, A. | Jones, S. | +3

9

Antibiotic prophylaxis in vaccinated eculizumab recipients who developed meningococcal disease

enthalten in: The Journal of infection | 2020

von Crew, P. | McNamara, L. | Waldron, P. | +3

10

BCR‐ABL1 tyrosine kinase inhibitor‐associated thyroid dysfunction : A review of cases reported to the FDA Adverse Event Reporting System and published in the literature

enthalten in: American Journal of Hematology | 2020

von Patel, S. | Nayernama, A. | Jones, S. | +2

1
2
3
4
5
Nächster »
[5]